Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 40 Lung Neoplasms 34 Leukemia, Myeloid, Acute 34 Breast Neoplasms 31 Multiple Myeloma 25 Carcinoma, Non-Small-Cell Lung 25 Colorectal Neoplasms 23 Prostatic Neoplasms 21 Pancreatic Neoplasms 20 Melanoma 17 Carcinoma, Renal Cell 17 Lymphoma 16 Urinary Bladder Neoplasms 15 Triple Negative Breast Neoplasms 15 Ovarian Neoplasms 14 Myelodysplastic Syndromes 14 Burkitt Lymphoma 12 Lymphoma, Large B-Cell, Diffuse 11 Squamous Cell Carcinoma of Head and Neck 10 Sarcoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Glioma 10 Fallopian Tube Neoplasms 10 Mouth Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Transitional Cell 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Oropharyngeal Neoplasms 8 Laryngeal Neoplasms 8

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cystic Neoplasm × Specimen Handling × 30 days × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡